Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
acute migrane
acute myeloid leukemia
alx oncology
autoimmune diseases
bain capital
bausch health
berkeley lights
biotech ipos
boston blog main
boston top stories
breast cancer
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
deals
deerfield healthcare technology acquisitions
deerfield management company
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
europe blog main
europe top stories
fda
generic drug
glaxosmithkline
immunotherapy
impel neuropharma
investing
kidney disease
medical device
medicare
What
biotech
companies
days
hasn’t
ipo
2
×
ipos
2
×
slowed
2
×
activity
arrival
dog
drug
firm
industry
leading
life
line
market
migraine
momentum
new
pfizer
place
prep
raised
research
satsuma
science
securing
spinout
springworks
stopped
street
summer
summer’s
wall
week
welcomed
Language
unset
2
×
Current search:
slowed
×
ipo
×
unset
×
ipos
×
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
